DD297961A5 - Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und-cyanamide verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln - Google Patents

Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und-cyanamide verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Download PDF

Info

Publication number
DD297961A5
DD297961A5 DD90340878A DD34087890A DD297961A5 DD 297961 A5 DD297961 A5 DD 297961A5 DD 90340878 A DD90340878 A DD 90340878A DD 34087890 A DD34087890 A DD 34087890A DD 297961 A5 DD297961 A5 DD 297961A5
Authority
DD
German Democratic Republic
Prior art keywords
carbon atoms
chain
straight
branched alkyl
optionally substituted
Prior art date
Application number
DD90340878A
Other languages
German (de)
English (en)
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Romanis Fruchtmann
Christian Kohlsdorfer
Pia Theisen-Popp
Reiner Mueller-Peddinghaus
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD297961A5 publication Critical patent/DD297961A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
DD90340878A 1989-05-23 1990-05-21 Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und-cyanamide verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln DD297961A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3916663A DE3916663A1 (de) 1989-05-23 1989-05-23 Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
SG12695A SG12695G (en) 1989-05-23 1995-01-26 Substituted (quinoline-2-yl-methoxy) phenyl-acyl-sulphonamides and cyanamides process for their preparation and their use in medicines

Publications (1)

Publication Number Publication Date
DD297961A5 true DD297961A5 (de) 1992-01-30

Family

ID=25881158

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90340878A DD297961A5 (de) 1989-05-23 1990-05-21 Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und-cyanamide verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Country Status (18)

Country Link
US (1) US5091392A (pt)
EP (1) EP0399291B1 (pt)
JP (1) JP3004678B2 (pt)
KR (1) KR100210214B1 (pt)
AT (1) ATE108777T1 (pt)
AU (1) AU627579B2 (pt)
CA (1) CA2017135C (pt)
DD (1) DD297961A5 (pt)
DE (2) DE3916663A1 (pt)
DK (1) DK0399291T3 (pt)
ES (1) ES2056294T3 (pt)
HK (1) HK33395A (pt)
HU (1) HU215833B (pt)
IE (1) IE63593B1 (pt)
IL (1) IL94465A (pt)
PT (1) PT94105B (pt)
SG (1) SG12695G (pt)
ZA (1) ZA903939B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139751A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
US5360909A (en) * 1992-03-23 1994-11-01 Terumo Kabushiki Kaisha Phenoxyacetic acid compounds and medical preparations containing them
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
GB2356139A (en) * 1999-11-15 2001-05-16 Bayer Ag Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
EP2561870A1 (en) * 2007-03-30 2013-02-27 Tioga Pharmaceuticals, Inc. Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant and Alternating Irritable Bowel Syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
DE3867401D1 (de) * 1987-03-18 1992-02-13 American Home Prod Sulfonylcarboxamide.
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate

Also Published As

Publication number Publication date
IE63593B1 (en) 1995-05-17
IE901851L (en) 1990-11-23
ZA903939B (en) 1991-03-27
EP0399291B1 (de) 1994-07-20
PT94105B (pt) 1996-11-29
ES2056294T3 (es) 1994-10-01
HU215833B (hu) 2001-06-28
CA2017135A1 (en) 1990-11-23
DK0399291T3 (da) 1994-11-14
CA2017135C (en) 2001-07-10
HK33395A (en) 1995-03-17
SG12695G (en) 1995-06-16
US5091392A (en) 1992-02-25
KR100210214B1 (ko) 1999-07-15
IL94465A0 (en) 1991-03-10
JP3004678B2 (ja) 2000-01-31
DE3916663A1 (de) 1990-11-29
KR900018037A (ko) 1990-12-20
PT94105A (pt) 1991-01-08
HUT54655A (en) 1991-03-28
DE59006474D1 (de) 1994-08-25
HU903132D0 (en) 1990-10-28
AU5586790A (en) 1990-11-29
JPH035459A (ja) 1991-01-11
EP0399291A3 (de) 1991-03-06
ATE108777T1 (de) 1994-08-15
IL94465A (en) 1994-07-31
AU627579B2 (en) 1992-08-27
EP0399291A2 (de) 1990-11-28

Similar Documents

Publication Publication Date Title
EP0344519B1 (de) Substituierte 4-(Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate
DD297961A5 (de) Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und-cyanamide verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0339416B1 (de) Gegebenenfalls alpha-substituierte 4-(Chinolin-2-yl-methoxy)phenylessigsäuren und -ester
EP0261539A2 (de) Substituierte Phenylsulfonamide
EP0414078B1 (de) Disubstituierte (Chinolin-2-yl-methoxy) phenylessigsäure-Derivate
DE3617183A1 (de) Substituierte benzylether
EP0414019B1 (de) Substituierte N-(Chinolin-2-yl-methoxy)benzylsulfonylharnstoffe
EP0499926B1 (de) 2-Substituierte Chinoline, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0414076B1 (de) Cyclisch substituierte (Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate
EP0425906A2 (de) Substituierte Cycloalkano[b]dihydroindol- und -indolsulfonamide
EP0582908B1 (de) 2-Substituierte Chinolylmethoxy-phenylessigsäure- und -benzylacyl Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Leukotriensynthese Hemmer
EP0529450B1 (de) Substituierte Mandelsäurederivate, als 5-Lipoxygenasehemmer
DE4139751A1 (de) Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
EP0530639A1 (de) Heterocyclisch substituierte Chinolylmethoxy-Phenylacetamide als Lipoxygenasehemmer
EP0387610A2 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-N,N'-sulfonyl-harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0574774A1 (de) Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenyl-essigsäurederivate
EP0428860B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-carbonyl-harnstoffe
EP0545170A1 (de) Chinolylmethoxyphenyl-essigsäureamide
EP0582916A1 (de) N-Methansulfonyl-2- 3-isobutyl-3-(chinolin-2-yl-methoxy)phenyl -2-cycloalkylessigsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0424722B1 (de) Substituierte (Chinolin-2-yl-methoxy)phenyl-thioharnstoffe
DE4139750A1 (de) Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
DD283812A5 (de) Messschaltung fuer schwache medienstroeme

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee